Case number 1:17-cv-00817
Amgen Inc. v. Macleods Pharmaceuticals, Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 20, 2020 | 1 | Complaint (10) |
| Apr 10, 2018 | 52 | SO ORDERED (2) Docket Text: SO ORDERED - re (42 in 1:17-cv-00815-GMS, 50 in 1:17-cv-00817-GMS) Stipulation of Admissibility filed by Amgen Inc.. Signed by Judge Gregory M. Sleet on 4/10/2018. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00817-GMS(mdb) |
| Apr 10, 2018 | 54 | Patent/Trademark Report to Commissioner (5) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) |
| Apr 10, 2018 | 53 | SO ORDERED (4) Docket Text: SO ORDERED - re [51] Proposed Consent Judgment filed by Amgen Inc., CONSENT JUDGMENT. Signed by Judge Gregory M. Sleet on 4/10/2018. ***Civil Case Terminated*** (mdb) |
| Mar 30, 2018 | 51 | Proposed Consent Judgment (4) Docket Text: PROPOSED CONSENT JUDGMENT by Amgen Inc.. (Blumenfeld, Jack) |
| Mar 30, 2018 | 50 | Stipulation (2) Docket Text: STIPULATION of Admissibility by Amgen Inc.. (Blumenfeld, Jack) |
| Feb 1, 2018 | 49 | Order (3) Docket Text: ORDER On or before March 1, 2018, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, the information requested in this Order. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 2/1/18. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00816-GMS, 1:17-cv-00817-GMS(cak) |
| Dec 19, 2017 | 48 | Order (2) Docket Text: ORDER denying (18 in 1:17-cv-00817-GMS) MOTION for Judgment on the Pleadings filed by Macleods Pharmaceuticals, Ltd., Macleods Pharma USA, Inc., denying (20 in 1:17-cv-00817-GMS) MOTION for Sanctions filed by Macleods Pharmaceuticals, Ltd., Macleods Pharma USA, Inc., re (47 in 1:17-cv-00817-GMS, 23 in 1:17-cv-00815-GMS) Memorandum Opinion. Signed by Judge Gregory M. Sleet on 12/19/2017. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00817-GMS(asw) |
| Dec 19, 2017 | 47 | Memorandum Opinion (5) Docket Text: MEMORANDUM OPINION re [18]Motion for Judgment on the Pleadings, re [20] Motion for Sanctions in C.A. No. 17-817 GMS. Signed by Judge Gregory M. Sleet on 12/19/2017. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00817-GMS(asw) |
| Dec 13, 2017 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Proposed Scheduling Order filed on 12/11/2017 has been replaced to correct the language in the settlement conference paragraph. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00816-GMS, 1:17-cv-00817-GMS(mdb) |
| Dec 13, 2017 | N/A | Remark (0) Docket Text: Remark - These cases have been consolidated for ALL PURPOSES. All future filings will be made ONLY in Lead C.A. No. 17-815-GMS. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00816-GMS, 1:17-cv-00817-GMS(mdb) |
| Dec 11, 2017 | 46 | Proposed Order (6) |
| Dec 11, 2017 | 46 | Main Document (6) Docket Text: PROPOSED ORDER -- Scheduling Order -- by Amgen Inc.. (Attachments: # (1) Letter to The Honorable Gregory M. Sleet from M. Noreika enclosing order)(Noreika, Maryellen) (Main Document 46 replaced on 12/13/2017) (mdb). |
| Dec 11, 2017 | 46 | Letter to The Honorable Gregory M. Sleet from M. Noreika enclosing order (1) |
| Dec 8, 2017 | 45 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Invalidity Contentions filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd..(Weinblatt, Richard) |
| Nov 29, 2017 | 44 | Transcript (24) Docket Text: Official Transcript of Conference held on 11 20 17 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 12/20/2017. Redacted Transcript Deadline set for 1/2/2018. Release of Transcript Restriction set for 2/27/2018. (kjm) |
| Nov 20, 2017 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Gregory M. Sleet - Scheduling Conference held on 11/20/2017. Discussion regarding the contents and differences in the joint status report. The Sherman Antitrust Act counterclaims are STAYED pending resolution of the patent claims. These cases will be consolidated for all purposes, including trial. A 5-day bench trial is set for 4/29/2019 at 9:00 AM in Courtroom 4A, and a Markman Hearing (1/2 day) is set for 4/2/2018 at 9:30 AM in Courtroom 4A, unless otherwise notified by the parties. The defendants will consult with their clients and inform the court, via the proposed amended scheduling order, if the Markman Hearing is necessary. The proposed amended scheduling order is due by 12/11/2017. (Court Reporter Kevin Maurer.) Associated Cases: 1:17-cv-00817-GMS, 1:17-cv-00815-GMS, 1:17-cv-00816-GMS(mdb) |
| Nov 9, 2017 | N/A | Oral Order (0) Docket Text: ORAL ORDER re (14 in 1:17-cv-00815-GMS, 20 in 1:17-cv-00816-GMS, 39 in 1:17-cv-00817-GMS) Joint Status Report - A Scheduling Conference is set for Monday, November 20, 2017 at 10:00 AM in Courtroom 4A. Ordered by Judge Gregory M. Sleet on 11/9/2017. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00816-GMS, 1:17-cv-00817-GMS(mdb) |
| Nov 3, 2017 | 43 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions Regarding Macleods filed by Amgen Inc..(Noreika, Maryellen) |
| Oct 25, 2017 | 42 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Discovery Production filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd..(Weinblatt, Richard) |
| Oct 18, 2017 | 41 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Disclosures filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd..(Weinblatt, Richard) |
| Oct 18, 2017 | 40 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Rule 26(a)(1) Initial Disclosures to Macleods; (2) Plaintiff's Disclosures Pursuant to District of Delaware Default Standard Paragraph 3 to Macleods; and (3) Plaintiff's Default Standard Paragraph 4(a) Disclosures to Macleods filed by Amgen Inc..(Noreika, Maryellen) |
| Oct 11, 2017 | 39 | Status Report (25) Docket Text: Joint STATUS REPORT by Amgen Inc.. (Noreika, Maryellen) |
| Oct 6, 2017 | 38 | Redacted Document (14) Docket Text: REDACTED VERSION of [37] Reply Brief by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Weinblatt, Richard) |
| Oct 4, 2017 | 36 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file Joint Status Report to October 11, 2017 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Murphy, Francis) |
| Oct 4, 2017 | N/A | SO ORDERED (0) |
| Oct 3, 2017 | 35 | Main Document (1) Docket Text: REDACTED VERSION of [30] Declaration by Amgen Inc.. (Attachments: # (1) Exhibit 1)(Blumenfeld, Jack) |
| Oct 3, 2017 | 35 | Exhibit 1 (46) |
| Oct 3, 2017 | 35 | Redacted Document (1) |
| Oct 3, 2017 | 34 | Redacted Document (13) Docket Text: REDACTED VERSION of [29] Answering Brief in Opposition by Amgen Inc.. (Blumenfeld, Jack) |
| Oct 2, 2017 | 33 | Declaration (3) |
| Oct 2, 2017 | 31 | Reply Brief (16) Docket Text: REPLY BRIEF re [18] MOTION for Judgment on the Pleadings filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Weinblatt, Richard) |
| Oct 2, 2017 | 32 | Redacted Document (27) Docket Text: REDACTED VERSION of [27] Answering Brief in Opposition to Motion for Judgment on the Pleadings by Amgen Inc.. (Blumenfeld, Jack) Modified on 10/3/2017 (mdb). |
| Oct 2, 2017 | 33 | Main Document (3) Docket Text: DECLARATION of Alicia A. Russo re [28] Declaration by Amgen Inc.. (Attachments: # (1) Exhibits 1-10)(Blumenfeld, Jack) Modified on 10/3/2017 (mdb). |
| Oct 2, 2017 | 33 | Exhibits 1-10 (121) |
| Sep 22, 2017 | 25 | Redacted Document (26) Docket Text: REDACTED VERSION of [20] MOTION for Sanctions by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Weinblatt, Richard) |
| Sep 22, 2017 | 26 | Redacted Document (2) |
| Sep 22, 2017 | 26 | Exhibits A - K (61) |
| Sep 22, 2017 | 26 | Main Document (2) Docket Text: REDACTED VERSION of [21] Declaration, by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Attachments: # (1) Exhibits A - K)(Weinblatt, Richard) |
| Sep 21, 2017 | N/A | SO ORDERED (0) |
| Sep 20, 2017 | 24 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit the Joint Status Report to October 4, 2017 - filed by Amgen Inc.. (Noreika, Maryellen) |
| Sep 18, 2017 | 22 | Redacted Document (16) Docket Text: REDACTED VERSION of [18] MOTION for Judgment on the Pleadings by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Weinblatt, Richard) |
| Sep 18, 2017 | 23 | Redacted Document (3) |
| Sep 18, 2017 | 23 | Main Document (3) Docket Text: REDACTED VERSION of [19] Declaration, by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Attachments: # (1) Exhibits A - O)(Weinblatt, Richard) |
| Sep 18, 2017 | 23 | Exhibits A - O (143) |
| Sep 7, 2017 | N/A | SO ORDERED (0) |
| Sep 1, 2017 | 17 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to File the Joint Status Report to September 20, 2017 - filed by Amgen Inc.. (Noreika, Maryellen) |
| Aug 29, 2017 | 16 | Redacted Document (13) Docket Text: REDACTED VERSION of [14] Answer to Counterclaim by Amgen Inc.. (Noreika, Maryellen) |
| Aug 25, 2017 | N/A | SO ORDERED (0) |
| Aug 24, 2017 | 15 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit the Joint Status Report to September 1, 2017 - filed by Amgen Inc.. (Noreika, Maryellen) |
| Aug 22, 2017 | N/A | SO ORDERED (0) |
| Aug 21, 2017 | 13 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Plaintiff to move, answer, or otherwise respond to Defendants' counterclaim to August 23, 2017 - filed by Amgen Inc.. (Blumenfeld, Jack) |
| Aug 10, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Erin R. Conway for Macleods Pharmaceuticals, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Jul 26, 2017 | 12 | Order (2) Docket Text: ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 7/26/2017. (asw) |
| Jul 21, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jul 19, 2017 | N/A | SO ORDERED (0) |
| Jul 18, 2017 | 11 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Shashank Upadhye, Joseph E. Cwik, and Erin R. Conway - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Weinblatt, Richard) |
| Jul 17, 2017 | 10 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Macleods Pharmaceuticals Ltd. for Macleods Pharma USA, Inc., Macleods Pharma USA, Inc. filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Weinblatt, Richard) |
| Jul 17, 2017 | 9 | Redacted Document (30) Docket Text: REDACTED VERSION of [8] Answer to Complaint, Counterclaim by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Weinblatt, Richard) |
| Jun 29, 2017 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Amgen Inc.. Macleods Pharma USA, Inc. served on 6/28/2017, answer due 7/19/2017. (Blumenfeld, Jack) |
| Jun 29, 2017 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Amgen Inc.. Macleods Pharmaceuticals, Ltd. served on 6/28/2017, answer due 7/19/2017. (Blumenfeld, Jack) |
| Jun 28, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00816-GMS, 1:17-cv-00817-GMS (rjb) |
| Jun 28, 2017 | N/A | Summons Reissued (0) Docket Text: Summons Reissued with Magistrate Consent Notice attached as to Macleods Pharmaceuticals, Ltd. (ceg) |
| Jun 23, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Macleods Pharma USA, Inc. on 6/26/2017; Macleods Pharmaceuticals, Ltd. on 6/26/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Jun 23, 2017 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amgen Inc. (nmg) |
| Jun 23, 2017 | 1 | Main Document (10) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2170205.) - filed by Amgen Inc.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(nmg) |
| Jun 23, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,375,405 B2. (nmg) |
| Jun 23, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/12/2017. Date of Expiration of Patent: 9/22/2026. (nmg) |
| Jun 23, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Jun 23, 2017 | 1 | Civil Cover Sheet (1) |
| Jun 23, 2017 | 1 | Exhibit A (14) |
| Jun 23, 2017 | 1 | Complaint* (1) |
